skip to main content
Close Icon We use cookies to improve your website experience.  To learn about our use of cookies and how you can manage your cookie settings, please see our Cookie Policy.  By continuing to use the website, you consent to our use of cookies.
Informa pharma logo

Financial Intelligence is part of the Informa Intelligence Division of Informa PLC

This is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

IFI Logo
Search Icon RecommendationsProduct loginProductLogin
Global Search Configuration

About Steven

USA

+6 year(s) experience

Steven Xinlei Shen, Manager of Quantitative Strategies, EPFR, headshot
Steven specializes in fund flow quantitative strategy development, new data product development, maintenance of all asset allocation strategies and fund flow product and research consultation.
He joined EPFR’s quantitative research team as an Analyst in 2013. In his role as a manager of quantitative strategies, he focuses on global/regional macro strategy, fixed income strategy, fund level strategy, premium daily strategy and stock flow strategy. He also covers new data product development, maintenance of all asset allocation strategies kept by the firm, and consultation to prospects and clients to leverage fund flow data into the research framework.

Previously based in Shanghai, China, Steven maintained all global asset allocation strategies as well as developed Asia dedicated country and sector strategies. He was one of the guest speakers at Fund Forum Asia 2015.

Specialties

  • Fund Flows
  • Stock Flows

Analyst Articles

Articles by Steven

  • EPFR Fund Flows

    Quants Corner

    By Steven Xinlei Shen 02 Jul 2019

    Quants Corner 0702

    EPFR Investment strategy 2019 : Established model telling investors not to climb on any EM bandwagons Of the 40 fastest growing economies in 2018 only one, Ireland, was a recognized developed market. Emerging Markets also have something of a monopoly on reform stories. So, the persistent underperformance of emerging markets compared to the developed markets counterparts over the past 12 months presents quantitative and ‘quantamental’ investors with a dilemma when it comes to selecting and deploying strategies.

    Topic Industry News

    Read blog